1 The e ect of liposome phospholipid composition has been assumed to be relatively unimportant because of the presumed inert nature of phospholipids. 2 We have previously shown that cationic liposome formulations used for gene therapy inhibit, through their cationic component, the synthesis by activated macrophages of the pro-in¯ammatory mediators nitric oxide (NO) and tumour necrosis factor-a (TNF-a).3 In this study, we have evaluated the ability of di erent cationic lipids to reduce footpad in¯ammation induced by carrageenan and by sheep red blood cell challenge. 4 Parenteral (i.p. or s.c) or local injection of the positively charged lipids dimethyldioctadecylammomium bromide (DDAB), dioleyoltrimethylammonium propane (DOTAP), dimyristoyltrimethylammonium propane (DMTAP) or dimethylaminoethanecarbamoyl cholesterol (DC-Chol) signi®cantly reduced the in¯ammation observed in both models in a dose-dependent manner (maximum inhibition: 70 ± 95%). 5 Cationic lipids associated with dioleyol-or dipalmitoyl-phosphatidylethanolamine retained their antiin¯ammatory activity while cationic lipids associated with dipalmitoylphosphatidylcholine (DPPC) or dimyristoylphosphatidylglycerol (DMPG) showed no anti-in¯ammatory activity, indicating that the release of cationic lipids into the macrophage cytoplasm is a necessary step for anti-in¯ammatory activity. The anti-in¯ammatory activity of cationic lipids was abrogated by the addition of dipalmitoylphosphatidylethanolamine-poly(ethylene)glycol-2000 (DPPE-PEG 2000 ) which blocks the interaction of cationic lipids with macrophages. 6 Because of the signi®cant role of protein kinase C (PKC) in the in¯ammatory process we have determined whether the cationic lipids used in this study inhibit PKC activity. The cationic lipids signi®cantly inhibited the activity of PKC but not the activity of a non-related protein kinase, PKA. The synthesis of interleukin-6 (IL-6), which is not dependent on PKC activity for its induction in macrophages, was not modi®ed in vitro or in situ by cationic lipids. The synthesis of NO and TNF-a in macrophages, both of which are PKC-dependent, was downregulated by cationic lipids. 7 These results demonstrate that cationic lipids can be considered as novel anti-in¯ammatory agents. The downregulation of pro-in¯ammatory mediators through interaction of cationic lipids with the PKC pathway may explain this anti-in¯ammatory activity. Furthermore, since cationic lipids have intrinsic anti-in¯ammatory activity, cationic liposomes should be used with caution to deliver nucleic acids for gene therapy in vivo.